Please note that the table compiling the EURONANOMED II JTC 2014 INDICATIVE FUNDING COMMITMENTS AND ELIGIBILITY in the call documents has been updated on Dec 19th

EuroNanoMed II Joint Transnational Call for Proposals (2014) for

“European Innovative Research & Technological Development Projects in



The 5th Call for Proposals of the EuroNanomed initiative is launched On November 26TH 2013

Through 4 successful Joint Transnational Calls launched from 2009 to 2013, the EuroNanoMed ERA-NET initiative has allocated about € 32 Million to transnational research projects in Nanomedicine.

The ERA-NET EuroNanoMed II launches a fifth Joint Call for Proposals to support transnational innovative research projects in Nanomedicine. Thirteen countries/regions are participating to this call for proposals: Belgium/Flanders, Belgium/Wallonia, France, Israel, Italy, Latvia, Lithuania, Norway, Poland, Portugal, Romania, Spain and Sweden.

Electronic submission website

Research project consortia who intend to submit a transnational proposal should register from January 14th 2014, at, following the instructions provided on the site.

Registration and electronic proposal submission must be completed before Tuesday 4th March 2014 17:00:00 CET.

Contact details for the Joint Call Secretariat:

Veneto Nanotech S.C.P.A.

+39 049 7705520

Call related documents:

Call text

Proposal submission form

Guidelines for applicants

JTC 2014 Pre-eligibility check form for ITALIAN RESEARCHERS

AIMs of the call:

The aims of the call are:

  • To support translational research proposals that combine innovative approaches (basic, clinical, industrial ) in the field of Nanomedicine and;
  • To encourage and enable transnational collaboration between public and private research groups from academia (research teams from universities, higher education institutions, public research institutions) and clinical/public health research (research teams from hospital/ public health, healthcare settings and other healthcare organizations) or research teams from industrial enterprises (all size). The participation of SMEs is encouraged.

TOPICS of the call:

Project proposals will address multidisciplinary and translational research. The project proposals must cover at least one of the following areas that are equal in relevance for this call:

  • Regenerative medicine
  • Diagnostics
  • Targeted delivery systems

General conditions for application:

A consortium applying to this call must include research group(s) from at least two out of the three following categories, if eligible according to relevant national/regional funding organisation’s regulations for research funding:

  • academia (research teams working in universities, other higher education institutions or research institutes);
  • clinical/public health research sector (research teams working in hospitals/public health and/or other health care settings and health organizations);
  • enterprise (all sizes of private companies). Participation of small and medium-size enterprises (SMEs) is encouraged.

Please note! Whilst applications will be submitted jointly by groups from several countries, individual groups will be funded by the individual EuroNanoMed II funding organization respective of the country/region from which applicants have applied. The applications are therefore subjected to eligibility criteria of individual funding organizations. Please note that the national eligibility conditions have evolved since the last EuroNanoMed call. Applicants are therefore strongly advised to contact their national representative as soon as possible in order to confirm their eligibility with their respective funding organizations.

Only transnational projects will be funded. Each proposal must involve a minimum of three research groups from three different countries including at least two eligible research groups from EuroNanoMed II country/regions participating in the 5th joint transnational call. The maximum number of participants in a project consortium is seven. Research groups not eligible to be funded (e.g. from non-funding countries or not fundable according to national/regional regulations of the participating funding countries) may participate in transnational projects if they are able to secure their own funding.

Contact Point list

Participant organisation name Country/region Contact details
Agentschap voor Innovatie door Wetenschap en Technologie (IWT) BELGIUM / FLANDERS

Dirk Veelaert (+32) 2 432 42 19

Fonds Wetenschappelijk Onderzoek (FWO) BELGIUM/ FLANDERS

Olivier Boehme: (+32) 2 550 545

Geertrui Poelaert: (+32) 2 550 555

Service public de Wallonie (SPW-DGO6) BELGIUM / WALLONIA

Nicolas Delsaux (+32) 81 33 45 20

Agence Nationale de la Recherche (ANR) FRANCE

Heidi Ligeret (+33) 1 78 09 80 44

Natalia Martin (+33) 1 73 54 81 33

Chief Scientist Office, Ministry Of Health (CSO-MOH) ISRAEL

Benny Leshem (+972) (0) 2 5082161

Ministero Della Salute (IMH) ITALY

Dr. Gaetano Guglielmi

Latvijas Zinatnu Akademija (LAS) LATVIA

Yuri Dekhtyar (+371) 670 89 383

Dace Tirzite (+371) 672 27 790

Lietuvos mokslo taryba (RCL) LITHUANIA

Jurgita Stonytė (+370) 5 261 8530

Norges Forskningsrad (RCN) NORWAY

Cecilie Anita Mathiesen

Narodowe Centrum Badan i Rozwoju (NCBR) POLAND

Dagmara Opoczyńska-Świeżewska(+48) 22 39 07 177

Fundação para a Ciência e a Tecnologia (FCT) PORTUGAL

Carlos Almeida Pereira (+351) 213924 397

Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI) ROMANIA

Mihaela Manole  (+40) 21 3023863

Instituto de Salud Carlos III (ISCIII) SPAIN

Ignacio Baanante (+34) 9182 22576

Vetenskapsradet – Swedish Research Council (SRC) SWEDEN

Johan Nilsson (+46) 8 546 44 202

Call documents





EuroNanoMed I & II call statistics

EuroNanoMed I & II call statistics

During the period 2009-2014, the ERA-NET EuroNanoMed I & II has successfully launched 5 joint calls for proposals.

The first 5 calls for proposals funded 40 transnational research projects on nanomedicine involving 217 partners from 21 countries/regions participating in the calls, with about € 38 million funding from the EuroNanoMed funding agencies and a further € 28 million funding from the research partners participating in the funded projects.

Country of origin of the applicants

Altogether, 914 partners from more than 21 countries participated in these calls, in a total of 192 submitted projects. As presented in figure 1, the number of applicants per country has globally grown between 2009 and 2014, as well as the number of submitted proposals (24 and 51 respectively).

pirmas Figure 1: Number of applicants per country for the first 5 calls for proposals.

*NPC (Non participating country) refers to applicants that belonged to countries where no funding organization participated in the joint transnational call.

Overview of the 5 calls

The table below summarizes the outcomes of the first 5 calls for proposals:


Participation of research organizations in translational projects in Nanomedicine

As EuroNanoMed I & II joint calls for proposals aimed at funding translational research projects in Nanomedicine, each consortium had to include teams from at least 2 of the following categories: academia, clinic/public health, industry. The distribution between these three categories among consortia funded in the 5 calls is outlined in Figure 2. Noteworthy, 61% of the funded projects included partners from all three categories, indicating the high added value of these collaborations in nanomedicine translational research.


Figure 2: Type of research organizations funded through the five EuroNanoMed I & II joint calls for proposals.

Scientific / technological areas covered by funded projects

The first 5 calls for proposals were open to projects covering at least one of the three priority topics of the European Technology Platform Nanomedecine: Targeted delivery systems, Diagnostics, Regenerative medicine. The coverage of these three scientific areas among funded projects is presented in figure 3.


Figure 3: Distribution of scientific areas covered by funded projects in the first 5 calls for proposals.